Pharmaceutical Market and Healthcare Services in Poland and Eastern Europe - Manufacturers

Bioton seals JV with Actavis

Mon, 30 Jan 2012 00:00:00 +0100

Bioton on 30 January signed a long-heralded joint-venture agreement with Actavis about the development and commercialisation of recombinant human insulin and short- and long-acting insulin ...

Biogened forecasts 43% sales growth in 2012

Mon, 23 Jan 2012 00:00:00 +0100

Biogened, a NewConnect-listed maker of Rx and OTC drugs, dietary supplements and dermocosmetics, expects to generate sales revenues of PLN 35.4m (€8.2m) this year, the company ...

Biomed Lublin announces maiden delivery of plasma to LFB of France

Tue, 17 Jan 2012 00:00:00 +0100

Biomed Lublin on 16 January announced that it has completed the first delivery of blood plasma to France’s Laboratoire Francais du Fractionnement et des Biotechnologies ...

Strong December lifts Sopharma’s Q4 sales growth into positive territory

Mon, 09 Jan 2012 00:00:00 +0100

Sopharma, the Bulgarian drug maker with a dual listing in Warsaw, announced a 38% year on year increase in sales revenues for the month of December 2011, helped by a recovery in export ...

Skotan to launch test production of dietary supplements in Q1 2012

Fri, 16 Dec 2011 00:00:00 +0100

Skotan, a listed maker of biofuels, on 15 December 2011 announced that it has been awarded a PLN 13.6m (€3m) EU grant from the Polish Agency for Enterprise Development (PARP) ...